While the CHA patients show the most antibodies against the A2 domain (76% CHA; 34% AHA), the anti‐FVIII antibodies in AHA patients are primarily directed against the C1C2 domain (AHA 77%; CHA 49%). Here, F8 is linked to autoimmune hemolytic anemia.